UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 297

Sortiert nach

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study

Arthritis research & therapy, 2018-12, Vol.20 (1), p.275-275, Article 275

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720-1759720X221114105

2022

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Arthritis research & therapy, 2019-04, Vol.21 (1), p.88-88, Article 88

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

Arthritis research & therapy, 2019-01, Vol.21 (1), p.11-11, Article 11

2019

Link zum Volltext

Verfügbarkeit prüfen

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

BMC musculoskeletal disorders, 2021-04, Vol.22 (1), p.372-372, Article 372

2021

Link zum Volltext

Verfügbarkeit prüfen

A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center

Journal of autoimmunity, 2021-02, Vol.117, p.102580-102580, Article 102580

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis

Therapeutic advances in musculoskeletal disease, 2020, Vol.12, p.1759720X20978139-1759720X20978139

2020

Link zum Volltext

Verfügbarkeit prüfen

Ectopic lymphoid neogenesis in psoriatic arthritis

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.720-726

2007

Link zum Volltext

Verfügbarkeit prüfen

Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians

Reumatología clinica (Barcelona), 2023-11, Vol.19 (9), p.515-526

2023

Link zum Volltext

Verfügbarkeit prüfen

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis

Frontiers in immunology, 2022-11, Vol.13, p.1001025-1001025

2022

Link zum Volltext

Verfügbarkeit prüfen

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15803

2022

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency

Journal of clinical medicine, 2021-09, Vol.10 (18), p.4160

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased risk of tuberculosis in patients with rheumatoid arthritis

Journal of rheumatology, 2003-07, Vol.30 (7), p.1436

2003

Link zum Volltext

Verfügbarkeit prüfen

Etanercept in the longterm treatment of patients with ankylosing spondylitis

Journal of rheumatology, 2009-06, Vol.36 (6), p.1256

2009

Link zum Volltext

Verfügbarkeit prüfen

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study

Diagnostics (Basel), 2022-01, Vol.12 (1), p.182

2022

Link zum Volltext

Verfügbarkeit prüfen

Ilium Osteitis as the Main Manifestation of the SAPHO Syndrome: Response to Infliximab Therapy and Review of the Literature

Seminars in arthritis and rheumatism, 2008-04, Vol.37 (5), p.299-306

2008

Link zum Volltext

Verfügbarkeit prüfen

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review

Journal of clinical medicine, 2023-02, Vol.12 (5), p.1734

2023

Link zum Volltext

Verfügbarkeit prüfen

Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study

Annals of the rheumatic diseases, 2015-08, Vol.74 (8), p.e42-e42

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study

Reumatología clinica, 2019-03, Vol.15 (2), p.102-108

2019

Link zum Volltext

Verfügbarkeit prüfen

Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13290

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of biological therapies for treating rheumatoid arthritis

Expert opinion on biological therapy, 2017-09, Vol.17 (9), p.1089-1103

2017

Link zum Volltext

Verfügbarkeit prüfen

Synovial tissue features associated with poor prognosis in inflammatory arthritis

Arthritis research & therapy, 2024-01, Vol.26 (1), p.18-18, Article 18

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(255)

Publikationsform

Artikel
(291)
Berichte
(5)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Life Sciences & Biomedicine
(180)
Rheumatology
(165)
Humans
(159)
Rheumatoid Arthritis
(145)
Male
(92)
Female
(91)
Middle Aged
(83)
Adult
(69)
Arthritis, Rheumatoid - Drug Therapy
(64)
Antirheumatic Agents - Therapeutic Use
(60)
Aged
(59)
Artritis Reumatoide
(51)
Biological And Medical Sciences
(46)
Medical Sciences
(45)
Diseases Of The Osteoarticular System
(41)
Arthritis
(37)
Inflammatory Joint Diseases
(30)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(30)
Arthritis, Rheumatoid - Diagnosis
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis

Ectopic lymphoid neogenesis in psoriatic arthritis

Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis

Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency

Increased risk of tuberculosis in patients with rheumatoid arthritis

Etanercept in the longterm treatment of patients with ankylosing spondylitis

Genetic variation associated with cardiovascular risk in autoimmune diseases

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study

Ilium Osteitis as the Main Manifestation of the SAPHO Syndrome: Response to Infliximab Therapy and Review of the Literature

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review

Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study

Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients

Safety profile of biological therapies for treating rheumatoid arthritis

Synovial tissue features associated with poor prognosis in inflammatory arthritis

Suchergebnisse filtern